Expanding Human Milk Fortifier Industry Predicted to Reach USD 9.9 Billion by 2034
The Human Milk Fortifier (HMF) market is experiencing significant growth, driven by product advancements and increasing clinical evidence supporting their benefits for preterm and very low birth-weight infants. The global HMF market is projected to grow from approximately USD 331.7 million in 2024 to USD 852.6 million by 2034, with a compound annual growth rate (CAGR) of 9.9% from 2025 to 2034 [1]. North America currently leads the market with over 47% share [1].
Product Advancements:
HMF products enhance mother's milk or donor human milk by adding concentrated protein, calcium, phosphorus, vitamins, and micronutrients essential for preterm infants' growth, leading to measurable weight and length gains [1]. The liquid HMF segment is rapidly growing and was valued at approximately USD 500 million in 2023, with expectations to reach USD 1.2 billion by 2032 [3]. Companies like Mead Johnson (Reckitt) have a strong presence in this segment.
Emphasis on human milk-based fortifiers is also growing, as research confirms that fortifiers based on human milk reduce the risk of necrotizing enterocolitis (NEC), a dangerous gut condition in preemies, compared to bovine-based formulas or fortifiers. Studies show up to a 90% reduction in NEC risk with human milk plus human milk fortifiers versus traditional cow milk-based formulas [4].
Accessibility and Industry Trends:
Major industry players such as Nestlé SA, Abbott Nutrition, and Mead Johnson continue to dominate the market and invest in expanding fortifier offerings [1][5]. However, adoption in some countries like India remains limited due to cost concerns, feed intolerance, and operational challenges [1].
Regulatory attention on infant formula safety, including the U.S. FDA’s Operation Stork Speed (2025) review, may boost usage and availability of safer human milk-based products, as it addresses nutrient standards and pushes for transparency and safety improvements [2].
Notable Products:
- MeadJohnson offers Enfamil Human Milk Fortifier, focusing on hydrolyzed proteins for easier digestion in preterm infants.
- Abbott has advanced its Similac Human Milk Fortifier with HMO to support preterm infants' immune systems.
- NeoLacta Lifesciences launched NeoLacta Forte, the first lyophilized (freeze-dried) human milk-derived fortifier in Asia.
- Nestle's Gerber Good Start Human Milk Fortifier incorporates probiotics to support gut health in preemies.
In summary, the human milk fortifier market is advancing with improved formulations and clinical backing for safety and efficacy, especially related to NEC prevention. However, broader accessibility efforts, particularly in emerging markets, remain a focal challenge amid rising market growth and product innovation led by major global players [1][3][4].
